^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SMYD3 inhibitor

    i
    Other names: SMYD3 inhibitor
    Associations
    News
    Trials
    Company:
    GSK, Stanford University
    Drug class:
    SMYD3 inhibitor
    Related drugs:
    Associations
    News
    Trials